Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?

Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD.

J Arthroplasty. 2010 Oct;25(7):1053-60. doi: 10.1016/j.arth.2009.06.021. Epub 2009 Aug 12.

2.

Cost-effective prophylaxis against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin.

Mostafavi Tabatabaee R, Rasouli MR, Maltenfort MG, Parvizi J.

J Arthroplasty. 2015 Feb;30(2):159-64. doi: 10.1016/j.arth.2014.08.018. Epub 2014 Sep 6.

PMID:
25534862
3.

A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.

PMID:
10901307
4.

A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.

Intermountain Joint Replacement Center Writing Committee..

J Arthroplasty. 2012 Jan;27(1):1-9.e2. doi: 10.1016/j.arth.2011.03.032. Epub 2011 May 31.

PMID:
21621959
5.

Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.

Vulcano E, Gesell M, Esposito A, Ma Y, Memtsoudis SG, Gonzalez Della Valle A.

Int Orthop. 2012 Oct;36(10):1995-2002. doi: 10.1007/s00264-012-1588-4. Epub 2012 Jun 12.

6.

Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.

Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT.

J Bone Joint Surg Am. 2007 Dec;89(12):2648-57.

PMID:
18056497
7.

Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control study.

Sadeghi B, Romano PS, Maynard G, Strater AL, Hensley L, Cerese J, White RH.

J Hosp Med. 2012 Nov-Dec;7(9):665-71. doi: 10.1002/jhm.1962. Epub 2012 Oct 5.

PMID:
23042665
8.

Mobile compression devices and aspirin for VTE prophylaxis following simultaneous bilateral total knee arthroplasty.

Nam D, Nunley RM, Johnson SR, Keeney JA, Barrack RL.

J Arthroplasty. 2015 Mar;30(3):447-50. doi: 10.1016/j.arth.2014.10.018. Epub 2014 Oct 22.

PMID:
25453630
9.

Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.

Asopa V, Cobain W, Martin D, Keene G, Bauze A.

ANZ J Surg. 2015 Sep;85(9):652-7. doi: 10.1111/ans.13174. Epub 2015 May 21.

PMID:
25997601
10.

DVT prophylaxis: better living through chemistry: affirms.

Pellegrini VD.

Orthopedics. 2010 Sep 7;33(9):642. doi: 10.3928/01477447-20100722-43.

PMID:
20839678
11.

Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.

Dager WE.

Ann Pharmacother. 2012 Jan;46(1):79-88. doi: 10.1345/aph.1P626. Epub 2011 Dec 27. Review.

PMID:
22202495
12.

Direct Costs of Aspirin versus Warfarin for Venous Thromboembolism Prophylaxis after Total Knee or Hip Arthroplasty.

Gutowski CJ, Zmistowski BM, Lonner JH, Purtill JJ, Parvizi J.

J Arthroplasty. 2015 Sep;30(9 Suppl):36-8. doi: 10.1016/j.arth.2015.04.048. Epub 2015 Jun 3.

PMID:
26073347
13.

Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.

Schousboe JT, Brown GA.

J Bone Joint Surg Am. 2013 Jul 17;95(14):1256-64. doi: 10.2106/JBJS.L.00400.

PMID:
23864173
14.

Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty.

Westrich GH, Haas SB, Mosca P, Peterson M.

J Bone Joint Surg Br. 2000 Aug;82(6):795-800.

15.

Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.

Wilson DG, Poole WE, Chauhan SK, Rogers BA.

Bone Joint J. 2016 Aug;98-B(8):1056-61. doi: 10.1302/0301-620X.98B8.36957. Review.

PMID:
27482017
16.

[Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].

Tian H, Song F, Zhang K, Liu Y.

Zhonghua Yi Xue Za Zhi. 2007 Dec 18;87(47):3349-52. Chinese.

PMID:
18478950
17.

Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.

Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA; INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism)..

Circulation. 2014 Sep 23;130(13):1062-71. doi: 10.1161/CIRCULATIONAHA.114.008828. Epub 2014 Aug 25.

18.

Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial.

Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T, Carrier M, Vendittoli PA.

Ann Intern Med. 2013 Jun 4;158(11):800-6. doi: 10.7326/0003-4819-158-11-201306040-00004.

PMID:
23732713
19.

Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.

Medjeral-Thomas N, Ziaj S, Condon M, Galliford J, Levy J, Cairns T, Griffith M.

Clin J Am Soc Nephrol. 2014 Mar;9(3):478-83. doi: 10.2215/CJN.07190713. Epub 2013 Dec 12.

20.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

Supplemental Content

Support Center